Abbott (ABT) Tops Q2 EPS by 1c, Updates FY EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- S&P 500, Nasdaq on track for record closing highs as focus turns to earnings
- Oil prices fall nearly 2% as Middle East supply concerns ease
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
- Goldman flags 2 key market risks if a climb in yields persists
- Shell CEO says Middle East oil flows reach 80% of prewar levels
- HubSpot to cut 7% of workforce in restructuring plan
- Paramount Skydance to close WBD deal, change ticker to SKYD
- Citi cuts investment banking analyst program to two years - Bloomberg
- Emera and Canadian Utilities agree to merge in $72B all-share deal
- Nasdaq notches record high close as investors focus on earnings
Abbott Labs (ABT) PT Raised to $56 at Deutsche Bank Following 2Q
July 21, 2017 8:37 AM EDTDeutsche Bank raised its price target on Abbott Labs (NYSE: ABT) to $56.00 (from $49.00) while maintaining a Buy rating following 2Q earnings report.... More
Abbott Labs (ABT) PT Raised to $57 at Barclays on 2Q Beat & FY17 EPS Raise; '2H Outlook Appears Bright'
July 21, 2017 8:32 AM EDTBarclays raised its price target on Abbott Labs (NYSE: ABT) to $57.00 (from $52.00) while maintaining a Overweight rating, following the company's second quarter earnings announcement.
Analyst Matthew Taylor notes the company delivered second quarter earnings per share and revenue results above the Street's... More
Abbott Labs (ABT) PT Raised to $62 at Argus on 2Q Beat & FY17 Raise; 'Positive View of Growth Prospects'
July 21, 2017 7:45 AM EDTArgus raised its price target on Abbott Labs (NYSE: ABT) to $62.00 (from $55.00) while maintaining a Buy rating, following the company's second quarter earnings announcement.
Analyst David Toung notes the company delivered second quarter earnings per share above consensus projections driven by positive... More



